¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

±¹¸³¾Ï¼¾ÅÍ 2022 Update for Colorectal Cancer Guideline & trials : 2022-07-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
±¹¸³¾Ï¼¾ÅÍ 2022 Update for Colorectal Cancer Guideline & trials : 2022-07-16
±³À°ÀÏÀÚ : 2022-07-16
±³À°Àå¼Ò : ±¹¸³¾Ï¼¾ÅÍ °ËÁøµ¿ 8Ãþ ´ë°­ÀǽǠ 
±³À°ÁÖÁ¦ : 2022 Update for Colorectal Cancer Guideline & trials
ÁÖÃÖ±â°ü : ±¹¸³¾Ï¼¾ÅÍ
´ã´çÀÚ : ÀÌ¿µ¼±
¿¬¶ôó : 031-920-2979  
À̸ÞÀÏ : yseel94@ncc.re.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú      
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 4 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 07-16 ·Îºñ 08:30~08:50 Registration  () 
±âŸ 07-16 ´ë°­ÀǽǠ08:50~09:00 Opening Ceremony  Kyung Su HAN(National Cancer Center) 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ09:00~09:15 Guidelines -Review & Evidences  Bun KIM(National Cancer Center) 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ09:15~09:30 Trials -Long-term Survival of High-risk T1 CRC  Kyung Su HAN(National Cancer Center) 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ09:30~09:50 Trials -Polyp Surveillance : Japan Experience (ON-LINE)  Masau SEKIGUCHI(National Cancer Center, Japan) 
Åä·Ð 07-16 ´ë°­ÀǽǠ09:50~10:10 Discussion  () 
È޽Ġ07-16 ·Îºñ 10:10~10:25 Coffee break  () 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ10:25~10:40 Guidelines -Review & Evidences  Sung SilPARK(National Cancer Center) 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ10:40~10:55 Trials -SurgicalManagement and Oncologic Outcomes of Distal T-colon and D-colon Cancer  InHo SONG(Dongnam Institute of Radiological & Medical sciences) 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ10:55~11:10 Trials -Long-termOutcomes of Robot-assisted versus  Dong WoonLEE(National Cancer Center) 
Åä·Ð 07-16 ´ë°­ÀǽǠ11:10~11:30 Discussion  () 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ11:30~12:00 Lessens Big Clinical Trials for Stage IV or Meta-static CRC: The JCOG1007 and 0603 Trials (ON-LINE)  YukihideKANEMITSU(National Cancer Center, Japan) 
½Ä»ç 07-16 ½Ä´ç 12:00~13:00 Lunch  () 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ13:00~13:15 Guidelines -Review & Evidences  MinJung KIM(Seoul National University Hospital) 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ13:15~13:30 Trials -Timingof Surgery for Resectable-synchronous Metastasis  Eon ChulHAN(Dongnam Institute of Radiological & Medical sciences) 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ13:30~13:45 Trials -Surgical Management for Peritoneal Carcinomatosis  SeungHyukBAIK(Gangnam Severance Hospital) 
Åä·Ð 07-16 ´ë°­ÀǽǠ13:45~14:05 Discussion  () 
È޽Ġ07-16 ·Îºñ 14:05~14:20 Coffee break  () 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ14:20~14:35 Guidelines -Reviews & Evidences(Chemotherapy)  Moon Ki CHOI(National Cancer Center) 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ14:35~14:50 Guidelines -Reviews & Evidences(Radiotherapy)  JeongIl YU(Samsung Medical Center) 
±³À°½Ã°£ 07-16 ´ë°­ÀǽǠ14:50~15:05 Trials -Update on Treatment Guidelines and Expanding Options for Metastatic CRC  JiYeonBAEK(National Cancer Center) 
Åä·Ð 07-16 ´ë°­ÀǽǠ15:05~15:25 Discussion  () 
±âŸ 07-16 ´ë°­ÀǽǠ15:25~15:30 Closing Remark  Kyung Su HAN(National Cancer Center) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ±¹¸³¾Ï¼¾ÅÍ 2022 Update for Colorectal Cancer Guideline & trials : 2022-07-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022 ´ëÇѺñ¸¸ÇÐȸ Obesity Summer Çмú´ëȸ : 2022-07-16
´ÙÀ½±Û ¿ï»ê´ëÇб³º´¿ø ¿ï»ê À̺ñÀÎÈÄ°ú Çмú ¼¼¹Ì³ª : 2022-07-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 34 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 34 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 30 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 25 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 29 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 41 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 23 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 22 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 21 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 19 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 25 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 26 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷